Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Ivermectin Cancer Research, Antiparasitic Drug Repurposing

Rajiv Bhatt

PhD

🏢University of Texas MD Anderson Cancer Center🌐USA

Associate Professor of Oncology and Pharmacology

37
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Rajiv Bhatt investigates the anti-cancer mechanisms of ivermectin and other antiparasitic drugs. His laboratory has characterized how ivermectin inhibits PAK1 kinase, disrupts mitotic spindle assembly, and inhibits WNT-TCF signaling in cancer cells. He conducts preclinical studies in breast cancer and glioblastoma models demonstrating anti-tumor efficacy of ivermectin alone and in combination with standard therapies. His work contributes to the translational evidence base supporting clinical trials of ivermectin repurposing in cancer.

Share:

🧪Research Fields 研究领域

ivermectin
cancer drug repurposing
PAK1 inhibition
breast cancer
antiparasitic drugs

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Rajiv Bhatt 的研究动态

Follow Rajiv Bhatt's research updates

留下邮箱,当我们发布与 Rajiv Bhatt(University of Texas MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment